GenScript Biotech Reports Full Year 2020 Financial Results and Business Results

Reported a revenue of approximately USD 390 million, a 42.9% YoY increase, and a gross profit of USD 260 million, achieving YoY growth of 41.9%. The Group’s non-cell therapy business witnessed its fastest growth in five years with a net profit increase of more than 100%; while its cell…

Continue Reading

HEDGE accordingly